U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842134) titled 'A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E' on Feb. 11.
Brief Summary: This is a phase 1, prospective, single-center, randomized sequence, open label, 2-way crossover study comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E.
It is planned to randomize approximately 16 healthy male and female subjects. All study periods will be completed during a single residency, the overall duration of residency will be 11 days (10 nights).
Study Start Date: Jan. 27
Study Type: INTERVENTIONAL
Condition:
Parenteral Nutrition
Intervention:
DRUG: Numeta G16%E
Numeta G16%...